Seeing the sheer innovation, drive, and expertise on display made me incredibly proud of our Canadian tech ecosystem. There is a healthy, competitive drive between nations at these global events, but ultimately, that competition is what pushes all of us to build better technology.
– James Core, Grants and Investor Relations Analyst
It was a pleasure for Dova to attend VivaTech 2026 this past June, having been selected as a Tech for Change company at the Canadian Pavilion. Taking place from June 17th to 20th in Paris, France, our team was represented by our CEO, Solveig Johannessen, as well as our Grants and Investor Relations Analyst James Core.
Hailing as Europe’s largest tech event where “business meets innovation,” VivaTech unites industry leaders, healthcare organizations, and investors from around the world to engage with some of today’s most transformative innovations and explore pathways for new, valuable collaborations across sectors. We were excited to be immersed in a uniquely collaborative ecosystem, advancing dialogue surrounding today’s most pressing obstacles in digital health, AI, clinical research, and pharmaceutical innovation.
The event provided a valuable opportunity to highlight the world-class innovations of leaders from across industries while paving the way for new partnerships that will It allowed for our team to expand Dova’s international footprint, nurturing existing relationships across both Europe and Canada while simultaneously growing our network, and discuss real opportunities for key innovation collaborations and pilots through insightful, cross-industry exchange.
The Canadian Pavilion featured Canadian innovation on the global stage, with exhibitors from across the country showcasing their cutting-edge innovations to key decision-makers and industry leaders. As part of the Canadian delegation, we had the pleasure of reaching both local and international partners; accelerating our exposure, supporting our growth, and opening the door to new conversations with like-minded industry executives. The Canadian delegation was led by SCALE AI, Canada’s artificial intelligence cluster.
Our designation as an official “Tech for Change” company is granted to exhibitors that are displaying positive impact, strong technology, as well as viability in their business operations. The recognition marks a partnership between Axionable, Envision Energy, UNESCO, WWF and Groupe Les Echos-Le Parisien, highlights exhibitors that demonstrate measurable positive impact, strong technology, and business viability.
“Seeing the sheer innovation, drive, and expertise on display made me incredibly proud of our Canadian tech ecosystem. There is a healthy, competitive drive between nations at these global events, but ultimately, that competition is what pushes all of us to build better technology,” shares James, reflecting on the experience. “It was a phenomenal experience connecting with global leaders as we look to scale our technology overseas and share the impact of Dova’s products on a world stage.”
About Dova
Dova Health Intelligence is a precision health technology company developing AI-powered, image-based solutions for gastrointestinal care and clinical research to support more precise and consistent disease assessment, monitoring, and research.
Our flagship technologies include DovaVision UC, designed to support granular assessment of ulcerative colitis at scale, and DovaSound, designed to support rapid, standardized intestinal ultrasound image capture and assessment. These technologies are designed in collaboration with leading clinical institutions, gastroenterologists, researchers, key opinion leaders, and strategic partners, with the goal of equipping clinicians and researchers with actionable insights and advancing the future of GI care.
